leisure time -WSS

leisure time

author：hotspot 2025-09-30 08:53:20 - browse：9382

Joe Biden in 2016. -- first opinion coverage from STAT — President Joe Biden Elise Amendola/AP

WASHINGTON — The latest phase of President Biden’s Cancer Moonshot initiative leaves open a few questions on how Congress might move forward with the program.

Since its launch in 2016, the federally funded cancer moonshot program has spurred thousands of scientific publications, 49 clinical trials, and more than 30 patent filings, according to a new report from the Congressional Research Service, the nonpartisan research arm of Congress.

The next phase of the cancer moonshot, according to Biden and his administration, is meant to emphasize cancer screening, prevention, and equitable treatment. The updated plan also seeks to speed progress on treatments for rare and childhood cancers, and it calls for supporting patients, survivors, and caregivers. The Advanced Research Projects Agency for Health (ARPA-H), a new agency tasked with taking big risks on biomedical and health technology, is also committing $240 million to cancer-related research and investing in new data-sharing platforms and a nationwide network for clinical trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： At JPM 2024, hospital systems pitch financial strength to investors

leisure time

WSS

In shift, Texas to cover initial consult for Afghan baby's gene therapy

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Physician assistants need a new name. Here's what it should be

STAT Virtual Event: JPM Recap, Live!

Ask STAT: What do you want to know about ChatGPT in medicine?

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

hotspot

leisure time

Wikipedia

Heart attack and stroke risk calculators need revising

The story of mRNA: From a loose idea to a tool that may help curb Covid

Supreme Court strikes down use of affirmative action

A preacher's new calling: Diversifying neuroscience research

Moonlake's readout produced a cash windfall. Risks remain

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Hepatitis C has a cure — but many Americans still lack access to it

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Drug repurposing or repositioning? The language matters

American taxpayers paid $1.8 trillion in health care costs in 2022

focus

With FDA staff opposed to Sarepta therapy, top official intervened

Death of patient in Alzheimer’s trial raises question of possible risks

STAT Virtual Event: JPM Recap, Live!

WATCH: Why do fingernails fall off when they're damaged?

Arena BioWorks launches in Cambridge to speed drug discovery

Does Paxlovid work in people vaccinated against Covid

entertainment

focus

leisure time

focus